Last week, CDC Director Rochelle Walensky cleared the path for Pfizer COVID-19 boosters to rollout to millions of Americans.
Walensky overruled the CDC Advisory Panel by making boosters available to all frontline workers.
Despite the lack of scientific data and approval of independent experts, Walensky once again chose politics over science.
Who’s the big winner of this politically-motivated decision?
The pharmaceutical company will reap hefty profits by producing millions of booster doses.
Pfizer’s profits from the experimental COVID-19 jabs are off the charts this year.
Pfizer is having a COVID.
Profit Q2 2021 $19 Billion = $211 million per day
Lucky for them they also make
Eliquis treats blood clots – sales up 13%
Vyndaqel treats cardiomyopathy – sales up 77%
Opportunity in all things.#COVID19
— Bernie's Tweets (@BernieSpofforth) September 23, 2021
"Pfizer is expected to generate $9.6 billion in sales of the vaccine in the third quarter and $11.4 billion in sales in the fourth quarter, for a total of $32.8 billion in COVID-19 vaccine sales in 2021"https://t.co/8PfYTVrleb
— The HighWire (@HighWireTalk) September 24, 2021
President Joe Biden is set to announce that the US is doubling its purchase of Pfizer's COVID-19 shots to share with the world to one billion doses as he embraces the goal of vaccinating 70% of the global population within the next year.
— Jamaica Gleaner (@JamaicaGleaner) September 22, 2021
Naturally, it makes sense Pfizer will want to provide boosters for as many individuals as possible.
During an appearance on ABC This Week, Pfizer CEO Albert Bourla was asked to predict the end of the ‘pandemic.’
Bourla estimated that normal life should return within a year.
However, there was a stipulation to that outcome.
Your old life only returns with the use of annual COVID-19 booster shots.
In other terms, Pfizer wants lifetime subscribers to their dangerous injections.
It’s not about saving lives.
Pfizer’s insatiable greed is their only motivation to administer injections across the globe.
Pfizer CEO says normal life will return within a year and adds we may need annual Covid shots https://t.co/4RXrxOUzzG
— CNBC (@CNBC) September 26, 2021
Of course the CEO of Pfizer will sell you the annual subscription plan:
"I don’t think that this means that we should be able to live our lives without having vaccinations"https://t.co/6oEFKpfoJR
— Milhouse Van Houten (@Milhouse_Van_Ho) September 27, 2021
The Pfizer CEO says we can get back to "normal life" in a year, but we'll need booster shots every year… aka Pfizer is guaranteed a profit of $3 billion extra a year on top of everything else they make. EAT SHIT.
— Tim Young (@TimRunsHisMouth) September 26, 2021
PFIZER CEO: Take this booster and we will get back to normal.
ALSO PFIZER CEO: You need a booster every year, because these shots eventually fail and we are never getting back to normal.
PFIZER CEO TO WALL STREET: We plan to make $26 billion on this booster.
— Tara Servatius (@TaraServatius) September 26, 2021
Summit News reported:
“Within a year, I think we will be able to come back to normal life,” said Bourla, although he made it very clear that this statement only applies to those who are prepared to take regular coronavirus booster shots.
“I don’t think that this means that variants will not be continuing coming,” Bourla added. “And I don’t think that this means that we should be able to live our lives without having vaccinations, basically.”
Bourla said that the “most likely scenario” was “annual re-vaccinations” due to the emergence of “new variants.”
The Pfizer’s CEO’s comments on annual vaccinations are interesting given that the FDA has so far only approved booster shots for elderly people and “high risk individuals.”
Bourla’s rhetoric is similar to that espoused by Moderna CEO Stephane Bancel, who said last week that even younger people will have to get vaccine booster shots at least once every three years.
This once again underscores how a two tier society is being created where only those who submit to regular shots will be able to enjoy a relatively normal lifestyle.
CNBC shared additional info:
In order to make that happen, Pfizer’s Bourla suggested it is likely annual coronavirus vaccine shots will be needed.
“The most likely scenario for me is that, because the virus is spread all over the world, that it will continue seeing new variants that are coming out,” Bourla said. “Also we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data.”
On Friday, the head of the Centers for Disease Control and Prevention Dr. Rochelle Walensky authorized the distribution of Pfizer and BioNTech’s Covid-19 booster shots for those in high-risk occupational and institutional settings, a move that overruled an advisory panel. Walensky approved distributing the booster shots to older Americans and adults with underlying medical conditions at least six months after their first series of shots, in line with the advisory panel.
The World Health Organization strongly opposes a widespread rollout of booster shots, saying wealthier nations should give extra doses to countries with minimal vaccination rates.
Bourla said on Sunday it is “not right to decide if you’re going to approve or not boosters” on any other criteria than “if the boosters are needed.”
On Tuesday, Tom Frieden, former head of the CDC, criticized Moderna and Pfizer for not sharing vaccination intellectual property more broadly to help accelerate global vaccination rates.
“While focusing on selling expensive vaccines to rich countries, Moderna and Pfizer are doing next to nothing to close the global gap in vaccine supply. Shameful,” Frieden said tweeted on Twitter.
Bourla said it is not a good idea to wave intellectual property.
“Intellectual property is what created the thriving life sciences sector that was ready when the pandemic hit,” Bourla said. “Without that, we wouldn’t be here to discuss if we didn’t with us or not because we wouldn’t have vaccines … Also, we are very proud of what we have done. I don’t know why [Frieden] is using these words. We are very proud. We have saved millions of lives.”
Pfizer is selling vaccines at different prices to countries with different levels of wealth. Developing countries are buying vaccines at cost from Pfizer, Bourla said. And Bourla pointed to the fact that Pfizer is selling one billion vaccine doses to the U.S. government at cost. The U.S. government is then donating those vaccine doses “at no cost, completely free, to the poorest countries of the world,” he said.